Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00148135
Recruitment Status : Terminated (recruitment goals met)
First Posted : September 7, 2005
Last Update Posted : January 10, 2008
Eli Lilly and Company
Information provided by:
University of Michigan Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : April 2006
  Actual Study Completion Date : October 2007